Orbital lymphangioma
Vitaly V Potemkin , Olga A Marchenko , Elena V Ageeva , Yuliya I Malakhova
Ophthalmology Reports ›› 2017, Vol. 10 ›› Issue (1) : 93 -96.
Orbital lymphangioma
In this article, clinical features, methods of diagnostic and treatment options of orbital lymphangioma are described.
| [1] |
1.Бровкина А.Ф. Офтальмоонкология. Руководство для врачей. – М.: Медицина, 2002. [Brovkina AF. Oftal’moonkologiya. Rukovodstvo dlya vrachey. Moscow: Meditsina; 2002. (In Russ.)] |
| [2] |
2.Blaniuk LT. Orbital vascular lesions. Role of imaging. Radiol Clin North Am. 1999;37:169-183. doi: 10.1016/S0033-8389(05)70085-3. |
| [3] |
3.Dryden RM, Wulc AE, Day D. Eyelid ecchymosis and proptosis in lymphangioma. Am J Ophthalmol. 1985;100:486-487. doi: 10.1016/0002-9394(85)90526-4. |
| [4] |
4.Gooding C, Meyer D. Intralesional bleomycin: a potential treatment for refractory orbital lymphangiomas. Ophthal Plast Reconstr Surg. 2014 May-Jun;30(3): e65-7. |
| [5] |
5.Graeb DA, Rootman J, Robertson WD, et al. Orbital lymphangiomas: clinical, radiologic, and pathologic characteristics. Radiology. 1990May;175(2):417-21. doi: 10.1148/radiology.175.2.2326469. |
| [6] |
6.Henderson JW, Campbell RJ, Farrow GM, Garrity JA. OrbitalTumors. New York: Raven Press; 1994. 43-52 pp. |
| [7] |
7.Hill RH, Shiels WE, Foster JA, et al. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations. Ophthal Plast Reconstr Surg. 2012 Mar-Apr;28(2):119-25. doi: 10.1097/IOP.0b013e318242ab0f. |
| [8] |
8.Harris GJ. Orbital vascular malformations: a consensus statement on terminology and its clinical implications. Orbital Society. Am J Ophthalmol. 1999Apr;127(4):453-5. |
| [9] |
9.Khan SN, Sepahdari AR. Orbital masses: CT and MRI of common vascular lesions, benign tumors, and malignancies. Saudi J Ophthalmol. 2012Oct;26(4):373-83. doi: 10.1016/j.sjopt.2012.08.001. |
| [10] |
10.Ko F, DiBernardo CW, Oak J, et al. Confirmation of and differentiation among primary vascular lesions using ultrasonography. Ophthal Plast Reconstr Surg. 2011Nov-Dec;27(6):431-5. doi: 10.1097/IOP.0b013e31822323af. |
| [11] |
11.Paramasivam S, Fay A, Fifi J, Berenstein A. O-015 image guided bleomycin sclerotherapy for orbital lymphatic malformation. J Neurointerv Surg. 2014Jul;6(Suppl):1:A8-9. doi: 10.1136/neurintsurg-2014-011343.15. |
| [12] |
12.Saha K, Leatherbarrow B. Orbital lymphangiomas: a review of management strategies. Curr Opin Ophthalmol. 2012Sep;23(5):433-8. doi: 10.1097/ICU.0b013e3283560a99. |
| [13] |
13.Shields JA, Bakewell B, Augsburger JJ, Flanagan JC. Classificationand incidence of space-occupying lesions of the orbit. Arch Ophthalmol. 1984;102:1606-1611. doi: 10.1001/archopht.1984.01040031296011. |
| [14] |
14.Suzuki Y, Obana A, Gohto Y. Management of orbital lymphangioma using intralesional injection of OK-432. Br J Ophthalmol. 2000Jun;84(6):614-7. doi: 10.1136/bjo.84.6.614. |
| [15] |
15.Shields JA. Diagnosis and management of orbital tumors. Philadelphia: WB Saunders; 1989. 149-169 p. |
| [16] |
16.Tunç M, Sadri E, Char DH. Orbital lymphangioma: an analysis of 26 cases. Br J Ophthalmol. 1999;83:76-80. doi: 10.1136/bjo.83.1.76. |
| [17] |
17.Yura J, Hashimoto T, Tsuruga N, Shibata K. Bleomycin treatment for cystic hygroma in children. Nippon Geka Hokan. 1977;46:607-14. |
Potemkin V.V., Marchenko O.A., Ageeva E.V., Malakhova Y.I.
/
| 〈 |
|
〉 |
PDF
